Trk and cAMP-dependent survival activity of adenosine A 2A agonist CGS21680 on rat motoneurons in culture

Neuroscience Letters

Volumn 522, Issue 1, 2012, Pages 21-24

  Komaki, Satoshi ^a,b   Ishikawa, Kiichiro ^a   Arakawa, Yoshihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AEON RETAIL Co Ltd   (Japan)

Author keywords

Adenosine; CGS21680; Motoneurons; Protein kinase A; Survival; Trk neurotrophin receptor

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR TRKB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; MOTONEURON; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RECEPTOR, TRKA;

EID: 84863781432     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.003     Document Type: Article

References (29)

1. Arakawa Y., Nishijima C., Shimizu N., Urushidani T. Survival-promoting activity of nimodipine and nifedipine in rat motoneurons: implications of an intrinsic calcium toxicity in motoneurons. Journal of Neurochemistry 2002, 83:150-156.
2. 2A receptor expression on motor neurons. Annals of Thoracic Surgery 2002, 74:846-849. (discussion 849-850).
3. Domeniconi M., Chao M.V. Transactivation of Trk receptors in spinal motor neurons. Histology and Histopathology 2010, 25:1207-1213.
4. Escandon E., Soppet D., Rosenthal A., Mendoza-Ramirez J.L., Szonyi E., Burton L.E., Henderson C.E., Parada L.F., Nikolics K. Regulation of neurotrophin receptor expression during embryonic and postnatal development. Journal of Neuroscience 1994, 14:2054-2068.
5. 2A receptor activation by endogenous adenosine. Neuropharmacology 2008, 54:924-933.
6. Fortunato J.J., Reus G.Z., Kirsch T.R., Stringari R.B., Fries G.R., Kapczinski F., Hallak J.E., Zuardi A.W., Crippa J.A., Quevedo J. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission 2010, 117:1131-1137.
7. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedebergs Archives of Pharmacology 2000, 362:364-374.
8. Galter D., Unsicker K. Brain-derived neurotrophic factor and TrkB are essential for cAMP-mediated induction of the serotonergic neuronal phenotype. Journal of Neuroscience Research 2000, 61:295-301.
9. Goda H., Ooboshi H., Nakane H., Ibayashi S., Sadoshima S., Fujishima M. Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist. European Journal of Pharmacology 1998, 357:149-155.
10. 2A receptor activation elicits long-lasting phrenic motor facilitation. Journal of Neuroscience 2008, 28:2033-2042.
11. Gomes C.V., Kaster M.P., Tome A.R., Agostinho P.M., Cunha R.A. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochimica et Biophysica Acta 2011, 1808:1380-1399.
12. Grundström E., Lindholm D., Johansson A., Blennow K., Askmark H. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis. Neuroreport 2000, 11:1781-1783.
13. Inoue S., Susukida M., Ikeda K., Murase K., Hayashi K. Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture. Biochemical and Biophysical Research Communications 1997, 238:468-472.
14. Krampfl K., Schlesinger F., Wolfes H., Dengler R., Bufler J. Functional diversity of recombinant human AMPA type glutamate receptors: possible implications for selective vulnerability of motor neurons. Journal of the Neurological Sciences 2001, 191:19-23.
15. Kust B.M., Copray J.C., Brouwer N., Troost D., Boddeke H.W. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Experimental Neurology 2002, 177:419-427.
16. Kwak S., Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. Journal of Molecular Medicine 2005, 83:110-120.
17. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998, 20:589-602.
18. Murray K.C., Nakae A., Stephens M.J., Rank M., D'Amico J., Harvey P.J., Li X., Harris R.L., Ballou E.W., Anelli R., Heckman C.J., Mashimo T., Vavrek R., Sanelli L., Gorassini M.A., Bennett D.J., Fouad K. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nature Medicine 2010, 16:694-700.
19. Nishijima C., Kimoto K., Arakawa Y. Survival activity of troglitazone in rat motoneurones. Journal of Neurochemistry 2001, 76:383-390.
20. 2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochemistry International 2010, 56:51-58.
21. Ochi M., Shiozaki S., Kase H. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease. Neuroscience 2004, 127:223-231.
22. Rumajogee P., Madeira A., Vergé D., Hamon M., Miquel M.C. Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. Journal of Neurochemistry 2002, 83:1525-1528.
23. Schubert P., Rudolphi K.A., Fredholm B.B., Nakamura Y. Modulation of nerve and glial function by adenosine-role in the development of ischemic damage. International Journal of Biochemistry 1994, 26:1227-1236.
24. Sen I., Nalini A., Joshi N.B., Joshi P.G. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor. Journal of the Neurological Sciences 2005, 235:45-54.
25. Tomimatsu N., Arakawa Y. Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP-protein kinase A-mediated survival. Journal of Neurochemistry 2008, 107:628-635.
26. Uhlenbrock K., Gassenhuber H., Kostenis E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cellular Signalling 2002, 14:941-953.
27. Weaver D.R. A1-adenosine receptor gene expression in fetal rat brain. Brain Research: Developmental Brain Research 1996, 94:205-223.
28. 2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:17210-17215.
29. Wootz H., Enjin A., Wallén-Mackenzie A., Lindholm D., Kullander K. Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice. Neurobiology of Disease 2010, 37:58-66.